Get started
Author

Helen Eze

Observed names: Eze, Helen, H. Eze
OpenAlex ID: A5012117706
Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial
2022 · Abigail S. Baldridge, Kasarachi Aluka-Omitiran, et al. · Implementation Science Communications · 40
PDF
Characteristics and Patterns of Retention in Hypertension Care in Primary Care Settings From the Hypertension Treatment in Nigeria Program
2022 · Jiancheng Ye, Ikechukwu A. Orji, et al. · JAMA Network Open · 28
PDF
Stakeholder perspectives on Nigeria’s national sodium reduction program: Lessons for implementation and scale-up
2023 · Olutobi A. Sanuade, Vanessa Alfa, et al. · PLoS ONE · 14
PDF
Fixed‐dose combination therapy‐based protocol compared with free pill combination protocol: Results of a cluster randomized trial
2023 · Olutobi A. Sanuade, Boni M. Ale, et al. · Journal of Clinical Hypertension · 11
PDF
Clinical characteristics and treatment patterns of pregnant women with hypertension in primary care in the Federal Capital Territory of Nigeria: cross-sectional results from the hypertension treatment in Nigeria Program
2023 · Zainab Mahmoud, Ikechukwu A. Orji, et al. · BMC Pregnancy and Childbirth · 7
PDF
Abstract 13217: Optimizing Longitudinal Retention in Care Among Patients With Hypertension in Primary Healthcare Settings: Findings From the Hypertension Treatment in Nigeria Program
2022 · Jiancheng Ye, IKECHUKWU ANTHONY A ORJI, et al. · Circulation · 7
Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial
2025 · Jiancheng Ye, Lisa R. Hirschhorn, et al. · Implementation Science · 6
Nigeria healthcare worker SARS-CoV-2 serology study: Results from a prospective, longitudinal cohort
2023 · Dike B. Ojji, Amelia Sancilio, et al. · PLOS Global Public Health · 4
PDF
The Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Sub-Saharan Africa (A Pilot Study)
2021 · Dike Ojji, Boni Maxime Ale, et al. · Frontiers in Cardiovascular Medicine · 4
PDF
Effects of a Pragmatic Type 2 Hybrid Interrupted Time Series Trial on Hypertension Treatment and Control in Nigeria
2024 · Dike Ojji, Abigail S. Baldridge, et al. · Research Square · 2
Hypertension Treatment in Nigeria (HTN) Program Rationale and Design for a Type 2 Hybrid, Effectiveness, and Implementation Interrupted Time Series Trial
2022 · Abigail Baldridge, Kasarachi Aluka-Omitiran, et al. · Research Square · 2
PDF
Abstract MP19: Characteristics And Patterns Of Retention In Hypertension Care In Primary Care Settings: Findings From The Hypertension Treatment In Nigeria Program
2022 · Jiancheng Ye, Ikechukwu Orji, et al. · Circulation · 2
Additional file 1 of Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial
2026 · Ye, Jiancheng, Hirschhorn, Lisa R., et al. · Figshare
Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial
2026 · Ye, Jiancheng, Hirschhorn, Lisa R., et al. · Figshare
Abstract P099: Fixed-dose Combination Therapy-based Protocol Compared With Nigeria’S National Hypertension Treatment Protocol: Results Of A Cluster Randomized Trial
2022 · Olutobi Sanuade, Boni Ale, et al. · Circulation
The Quantitative and Qualitative Analysis of Phytochemical Natural Constituents of Ethanolic Leaf Extracts of Solanum Aethiopicum
2021 · C.N. Ozoh, Gloria Chinelo Ike, et al. · International Journal of Trend in Scientific Research and Development
Mon-322 Emphysematous Pyelonephritis Presenting With Acute Kidney Injury, Treated With Antibiotics in a Black Woman in Sub-saharan Africa – a Case Report
2019 · F.N. Oguejiofor, H. Eze, et al. · Kidney International Reports
PDF
Works count: 25
Citation count: 127
H-index: 6
I10-index: 4
Year
Topic
Type